Ranolazine in Ischemic Cardiomyopathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01345188
Recruitment Status : Completed
First Posted : April 29, 2011
Last Update Posted : September 25, 2014
Gilead Sciences
Information provided by (Responsible Party):
Dr. Nicolas Shammas, Midwest Cardiovascular Research Foundation

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2014
  Actual Study Completion Date : April 2014

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 January 3, 2016
February 1, 2016
2 March 25, 2016
April 27, 2016
3 March 25, 2017
May 4, 2017
4 April 19, 2018
May 18, 2018